Dr Lal Pathlabs

{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,405.00",
    "chg": -15.15,
    "chgp": "-1.07%",
    "dir": -1,
    "prev_price": "1,420.15",
    "mcapval": "23,292.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE600L01024",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.07 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Has Dr Lal Pathlabs Ltd declared dividend?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/has-dr-lal-pathlabs-ltd-declared-dividend-3815076",
        "imagepath": "",
        "date": "2026-02-01 23:30:59",
        "description": "Dr Lal Pathlabs Ltd has declared a dividend.\n\nDividend Details:\n- Percentage announced: 35%\n- Amount per share: 7\n- Ex-date: 05 Feb 26\n\nDividend Yield: 0.91%.\n\nTotal Returns by Period:\nIn the last 3 months, the price return was -7.73%, the dividend return was 0.65%, resulting in a total return of -7.08%.\n\nOver the past 6 months, the price return was -7.94%, the dividend return was 1.03%, leading to a total return of -6.91%.\n\nIn the last year, the price return was -1.01%, the dividend return was 1.61%, culminating in a total return of 0.6%.\n\nOver the past 2 years, the price return was 15.29%, the dividend return was 4.76%, resulting in a total return of 20.05%.\n\nIn the last 3 years, the price return was 38.36%, the dividend return was 6.56%, leading to a total return of 44.92%.\n\nOver the past 4 years, the price return was 1.02%, the dividend return was 5.75%, culminating in a total return of 6.77%.\n\nIn the l..."
      },
      {
        "title": "Dr Lal Pathlabs Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-reports-flat-quarterly-performance-amid-margin-pressures-3813510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DrLalPathlabsLt_fintrenddot_3813510.png",
        "date": "2026-02-01 08:00:33",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. The company’s earnings per share (EPS) have declined to a quarterly low of ₹5.40, reflecting mounting pressures on profitability and signalling a cautious outlook for investors."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-sell-3812571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_mojoScore_3812571.png",
        "date": "2026-01-31 10:10:20",
        "description": "Dr Lal Pathlabs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Dr Lal Pathlabs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-dr-lal-pathlabs-ltd-latest-results-good-or-bad-3811911",
        "imagepath": "",
        "date": "2026-01-30 19:25:06",
        "description": "Dr. Lal PathLabs Ltd's latest financial results for Q3 FY26 indicate a solid operational performance, showcasing the company's ability to maintain growth amidst competitive pressures. The company reported a net profit of ₹150.40 crore, reflecting a year-on-year increase of 16.41%. Revenue also demonstrated a positive trend, with a year-on-year growth of 10.66%, reaching ₹730.60 crore. This marks the seventh consecutive quarter of year-on-year revenue growth, highlighting the company's consistent performance in a challenging market.\n\nOperating margins remained stable at 30.67%, indicating effective cost management despite inflationary pressures. Additionally, the PAT margin improved to 20.83%, up 102 basis points from the previous year, driven by enhanced operational leverage and a favorable tax rate. Employee costs, a significant expense for diagnostics firms, saw a slight increase but were managed effectiv..."
      },
      {
        "title": "Dr Lal PathLabs Q3 FY26: Strong Momentum Marred by Premium Valuation",
        "link": "https://www.marketsmojo.com/news/result-analysis/dr-lal-pathlabs-q3-fy26-strong-momentum-marred-by-premium-valuation-3811699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabs_quaterlyResult_3811699.png",
        "date": "2026-01-30 15:03:15",
        "description": "Dr Lal PathLabs Ltd., India's leading diagnostics chain, delivered a robust performance in Q3 FY26 (October-December 2025), with consolidated net profit surging 16.41% year-on-year to ₹150.40 crores, marking the company's strongest quarterly showing in recent periods. However, the stock has struggled to capitalise on this operational momentum, declining 8.83% over the past three months as investors grapple with stretched valuations and a bearish technical trend that emerged in mid-January."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-sell-3795949",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_mojoScore_3795949.png",
        "date": "2026-01-20 10:10:04",
        "description": "Dr Lal Pathlabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-forms-death-cross-signalling-potential-bearish-trend-3792244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/DrLalPathlabsLt_dealthcross_3792244.png",
        "date": "2026-01-14 18:00:39",
        "description": "Dr Lal Pathlabs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the healthcare services sector."
      },
      {
        "title": "Why is Dr Lal Pathlabs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lal-pathlabs-ltd-fallingrising-3790421",
        "imagepath": "",
        "date": "2026-01-13 01:18:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, accumulating a loss of 6.04% over this period. This decline is sharper than the sector’s average, with Dr Lal Pathlabs underperforming by 1.25% on the day. When compared to the broader market, the stock’s weekly return of -7.47% starkly contrasts with the Sensex’s more modest decline of -1.83%. Similarly, over the one-month and year-to-date periods, the stock has fallen by 3.23% and 6.20% respectively, while the Sensex has only dipped by 1.63% and 1.58% in the same intervals. This persistent underperformance highlights growing investor concerns specific to Dr Lal Pathlabs amid a relatively stable benchmark environment.</p>\n<p><strong>Technical Indicator..."
      },
      {
        "title": "Dr Lal Pathlabs Declines 3.77%: Mixed Technicals and Downgrade Shape Weekly Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-declines-377-mixed-technicals-and-downgrade-shape-weekly-trend-3788290",
        "imagepath": "",
        "date": "2026-01-10 14:00:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 5:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>Jan 6:</strong> Technical trend briefly turns mildly bullish</p>\n                    <p><strong>Jan 8-9:</strong> Downgrade to Sell and renewed bearish technical outlook</p>\n                    <p><strong>Jan 9:</strong> Week closes at Rs.1,417.00 (-3.77%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,502.25</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,417.00</div><div cl..."
      }
    ],
    "total": 279,
    "sid": "1000163",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025",
      "datetime": "30-Jan-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board approves Dividend",
      "datetime": "30-Jan-2026",
      "details": "Attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>35%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 19 Dec 25",
          "dt": "2025-12-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Has Dr Lal Pathlabs Ltd declared dividend?

2026-02-01 23:30:59

Dr Lal Pathlabs Ltd has declared a dividend. Dividend Details: - Percentage announced: 35% - Amount per share: 7 - Ex-date: 05 Feb 26 Dividend Yield: 0.91%. Total Returns by Period: In the last 3 months, the price return was -7.73%, the dividend return was 0.65%, resulting in a total return of -7.08%. Over the past 6 months, the price return was -7.94%, the dividend return was 1.03%, leading to a total return of -6.91%. In the last year, the price return was -1.01%, the dividend return was 1.61%, culminating in a total return of 0.6%. Over the past 2 years, the price return was 15.29%, the dividend return was 4.76%, resulting in a total return of 20.05%. In the last 3 years, the price return was 38.36%, the dividend return was 6.56%, leading to a total return of 44.92%. Over the past 4 years, the price return was 1.02%, the dividend return was 5.75%, culminating in a total return of 6.77%. In the l...

Read full news article

Dr Lal Pathlabs Reports Flat Quarterly Performance Amid Margin Pressures

2026-02-01 08:00:33

Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has reported a flat financial performance for the quarter ended December 2025, marking a significant shift from its previously positive growth trajectory. The company’s earnings per share (EPS) have declined to a quarterly low of ₹5.40, reflecting mounting pressures on profitability and signalling a cautious outlook for investors.

Read full news article

Dr Lal Pathlabs Ltd is Rated Sell

2026-01-31 10:10:20

Dr Lal Pathlabs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Dr Lal Pathlabs Ltd latest results good or bad?

2026-01-30 19:25:06

Dr. Lal PathLabs Ltd's latest financial results for Q3 FY26 indicate a solid operational performance, showcasing the company's ability to maintain growth amidst competitive pressures. The company reported a net profit of ₹150.40 crore, reflecting a year-on-year increase of 16.41%. Revenue also demonstrated a positive trend, with a year-on-year growth of 10.66%, reaching ₹730.60 crore. This marks the seventh consecutive quarter of year-on-year revenue growth, highlighting the company's consistent performance in a challenging market. Operating margins remained stable at 30.67%, indicating effective cost management despite inflationary pressures. Additionally, the PAT margin improved to 20.83%, up 102 basis points from the previous year, driven by enhanced operational leverage and a favorable tax rate. Employee costs, a significant expense for diagnostics firms, saw a slight increase but were managed effectiv...

Read full news article

Dr Lal PathLabs Q3 FY26: Strong Momentum Marred by Premium Valuation

2026-01-30 15:03:15

Dr Lal PathLabs Ltd., India's leading diagnostics chain, delivered a robust performance in Q3 FY26 (October-December 2025), with consolidated net profit surging 16.41% year-on-year to ₹150.40 crores, marking the company's strongest quarterly showing in recent periods. However, the stock has struggled to capitalise on this operational momentum, declining 8.83% over the past three months as investors grapple with stretched valuations and a bearish technical trend that emerged in mid-January.

Read full news article

Dr Lal Pathlabs Ltd is Rated Sell

2026-01-20 10:10:04

Dr Lal Pathlabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Dr Lal Pathlabs Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-14 18:00:39

Dr Lal Pathlabs Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the healthcare services sector.

Read full news article

Why is Dr Lal Pathlabs Ltd falling/rising?

2026-01-13 01:18:15

Recent Price Movement and Market Comparison

The stock has been on a downward trajectory for the past three consecutive days, accumulating a loss of 6.04% over this period. This decline is sharper than the sector’s average, with Dr Lal Pathlabs underperforming by 1.25% on the day. When compared to the broader market, the stock’s weekly return of -7.47% starkly contrasts with the Sensex’s more modest decline of -1.83%. Similarly, over the one-month and year-to-date periods, the stock has fallen by 3.23% and 6.20% respectively, while the Sensex has only dipped by 1.63% and 1.58% in the same intervals. This persistent underperformance highlights growing investor concerns specific to Dr Lal Pathlabs amid a relatively stable benchmark environment.

Technical Indicator...

Read full news article

Dr Lal Pathlabs Declines 3.77%: Mixed Technicals and Downgrade Shape Weekly Trend

2026-01-10 14:00:10

Key Events This Week

Jan 5: Technical momentum shifts amid mixed market signals

Jan 6: Technical trend briefly turns mildly bullish

Jan 8-9: Downgrade to Sell and renewed bearish technical outlook

Jan 9: Week closes at Rs.1,417.00 (-3.77%)

Week Open

Rs.1,502.25

Week Close

Rs.1,417.00

Read full news article

View All News